Clinical Trials
4
Active:0
Completed:3
Trial Phases
2 Phases
Early Phase 1:3
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Early Phase 1
3 (75.0%)Not Applicable
1 (25.0%)Testing Pediatric Rheumatology Diagnostic Decision Support in Clinical Use
Not Applicable
- Conditions
- Diagnostic Skills for Rheumatologic Conditions
- First Posted Date
- 2021-04-23
- Last Posted Date
- 2022-10-04
- Lead Sponsor
- PhenoSolve, LLC
- Target Recruit Count
- 15
- Registration Number
- NCT04856956
- Locations
- 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD
- First Posted Date
- 2019-11-18
- Last Posted Date
- 2021-07-02
- Lead Sponsor
- PhenoSolve, LLC
- Target Recruit Count
- 28
- Registration Number
- NCT04167189
- Locations
- 🇺🇸
NeurAbilitis, Voorhees, New Jersey, United States
Validating a New Non-invasive Approach to Testing Lidocaine Effectiveness
Early Phase 1
Completed
- Conditions
- ADHDControls
- Interventions
- First Posted Date
- 2018-09-21
- Last Posted Date
- 2020-07-15
- Lead Sponsor
- PhenoSolve, LLC
- Target Recruit Count
- 20
- Registration Number
- NCT03680885
- Locations
- 🇺🇸
Jacobi Medical Center, Bronx, New York, United States
Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD
- First Posted Date
- 2018-09-19
- Last Posted Date
- 2022-10-06
- Lead Sponsor
- PhenoSolve, LLC
- Target Recruit Count
- 90
- Registration Number
- NCT03676725
- Locations
- 🇺🇸
Boston Clinical Trials, Boston, Massachusetts, United States
🇺🇸Jacobi Medical Center, Bronx, New York, United States
News
No news found